Speakers: Eric L. Alexander James M. Beck Barbara R. Binis Lisa A. Chiarini Samuel F. Cullari Rudolf E. Hutz Melissa A. Geist Rachel B. Weil Brian T. Himmel Kelly H. Hibbert Thomas H. Suddath Marilyn A. Moberg

Event Type: CLE / CPD

Location Name:
Reed Smith's Philadelphia Office, Three Logan Square Suite 3100 1717 Arch Street, Philadelphia PA 19103
Start Date/Time:
10 November 2016, 8:30 AM ET
End Date/Time:
10 November 2016, 2:30 PM ET

Reed Smith’s Life Sciences Health Industry Group is pleased to offer a 1/2-day CLE covering hot topics and emerging litigation trends for in-house counsel.

Please join us for informative and practical sessions on Product Liability, Government Enforcement, Intellectual Property and Insurance issues impacting our pharmaceutical and medical device clients.

Sessions will include:

  • Major Drug and Device Decisions of 2016
    Presented by Eric Alexander (partner, Reed Smith LLP) and Kelly Hibbert (associate, Reed Smith LLP)
  • FCA Post-Escobar: Materiality Matters
    Presented by Thomas Suddath (partner, Reed Smith LLP), Brian Himmel (partner, Reed Smith LLP), and Lindsey Harteis (associate, Reed Smith LLP)
  • Purple is the New Orange: A Primer on the Biologics-Biosimilars Landscape
    Presented by Lisa Chiarini (partner, Reed Smith LLP) and Rudolf Hutz (counsel, Reed Smith LLP)
  • Looking for Law in All the Wrong Places: Perspectives on the Best (and Worst) Product Liability Jurisdictions
    Presented by Rick Fuentes, Ph.D. (jury consultant, R&D Strategic Solutions), Barbara Binis (partner, Reed Smith LLP), Melissa Geist (partner, Reed Smith LLP), and Marilyn Moberg (partner, Reed Smith LLP)
  • Regulating Healthcare on a New Wavelength: The FCC’s Role In Wireless Medical Devices
    Presented by Paul Bond (partner, Reed Smith LLP) and Samuel Cullari (counsel, Reed Smith LLP)
  • Implied Preemption – It’s Not Just for Generic Drugs Anymore (Plus Off-Label Promotions Update)
    Presented by James Beck (counsel, Reed Smith LLP) and Rachel Weil (counsel, Reed Smith LLP)

This program is geared toward in-house counsel; space is limited.